Navigation Links
NeuroSigma Receives Notice of Award from NIH for an STTR Grant for its Trigeminal Nerve Stimulation Therapy for Epilepsy
Date:9/6/2011

DeGiorgio and Ian Cook, UCLA faculty in the Departments of Neurology and Psychiatry, are the principal investigators of this project.  Together they have pioneered TNS for epilepsy, depression, post-traumatic stress disorder and other indications.

"We have already seen the safety and efficacy of our non-invasive eTNS™ therapy in prior clinical trials and look forward to the opportunity to further validate our therapy through the valuable funding provided by NINDS," said Dr. DeGiorgio.  "We are also very pleased to receive this grant knowing that NIH's highly regarded peer review process includes a rigorous review by leading medical experts."

CAUTION: The eTNS™ system is an investigational device and at this time is limited by United States law for investigational use only.

About NeuroSigma, Inc.

NeuroSigma is a Los Angeles-based medical technology company established to develop early stage technologies with the potential to transform medical practice. Currently, NeuroSigma is focused on a number of neuromodulation therapies and through our majority-owned subsidiary, NSVascular, on Thin-Film Nitinol covered stents for endovascular applications. NeuroSigma employs two neuromodulation therapy platforms: Trigeminal Nerve Stimulation (TNS) and Deep Brain Stimulation (DBS).  NeuroSigma has amassed significant intellectual property that is based on technology licensed on an exclusive basis from the University of California, Los Angeles (UCLA), including potential therapies for epilepsy, depression and post-traumatic stress disorder (PTSD) via TNS and for PTSD, obesity and cachexia via DBS. For more information about NeuroSigma, please visit our website at http://www.neurosigma.com.


'/>"/>
SOURCE NeuroSigma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. NeuroSigma Responds to Substantial Interest Generated by NPR Story on Promising Epilepsy Clinical Trial
2. NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLAs Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications
3. NeuroSigma, Inc. Retains CCG Investor Relations
4. Mesoblast Receives Clearance to Begin First European Trial of Allogeneic or Off-The-Shelf Stem Cell Treatment for Heart Attacks
5. Lupin Receives Final Approval to Market Generic Ultram® ER
6. Assured Pharmacy, Inc. Receives Gross Proceeds of $400,000 from Sale of Convertible Debentures and Warrants
7. Masimo Pronto-7™ Receives Japanese and Canadian Regulatory Clearances
8. Linagliptin Receives Approval in Europe for the Treatment of Type 2 Diabetes
9. Simceres Iremod Receives SFDA New Drug Approval
10. PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
11. WuXi AppTec Bioanalytical Services Unit Receives GLP Certificate from OECD and EU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... yesterday,s release of Center for Medicaid and Medicare services data ... to know: ... , As required ... Medicare and other government programs because it relies on competition ... benefits to enrollees. , Competition and rebates have been ...
(Date:5/1/2015)... Corporation (NASDAQ: THOR ), a world leader in mechanical ... announced today that Marta Antonucci has joined Thoratec ... This new Europe -based position is responsible ... America , including Europe , ... , and reports directly to the Chief Executive Officer. Following the ...
(Date:5/1/2015)... May 1, 2015  Legendary actor and director ... new PBAFacts campaign designed to educate and encourage patients ... about Pseudobulbar Affect (PBA) and to speak with their ... actor has the ability to cry and laugh on ... control experienced by people living with PBA episodes. ...
Breaking Medicine Technology:5 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3
... Corporation ( www.generex.com ) (OTC Bulletin Board: ... Antigen Express, Inc. ( www.antigenexpress.com ), announced today that ... Henry M. Jackson Foundation for the Advancement of Military ... on-going Phase II clinical study of Antigen,s AE37 novel ...
... FDLI,s Food and Drug Policy Forum (Volume 1, Number 2), ... important issue of genetically modified organisms (GMOs). In ... website ( www.fdli.org ), Ross H. Pifer, Director, and Richard ... and Reference Center at Penn State University,s Dickinson School of ...
Cached Medicine Technology:Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 2Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 3Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 4Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study 5FDLI's Food and Drug Policy Forum Examines European GMO Rules 2
(Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood ... their reclaimed wood products at the 27th annual International ... in NYC this May. Their newest offerings, Vat 35, ... texture and color to North America's platform for global ... and color in the design world and we're excited ...
(Date:5/1/2015)... 2015 Royal River Natural Foods, a ... on a new study that found two natural nutrients, ... improved physical function as well as standard drug treatment ... the knee. , The report is part of the ... Being® ,” which Royal River Natural Foods publishes for ...
(Date:5/1/2015)... TROY Healthcare Solutions is proud to ... Group (RUG) Conference in Atlanta, GA from May 6 ... Conference provides a forum for client-to-client presentations, continuing education ... of electronic medical record operations, as well as showcasing ... In addition to sponsoring the event, TROY Healthcare Solutions ...
(Date:5/1/2015)... Hope For The Warriors® thanks All ... The Warriors® and military families. All American Ford presented ... The Warriors®, a national nonprofit dedicated to restoring a ... hope for our service members and our military families. ... collected and matched small autograph fee from fans and ...
(Date:5/1/2015)... CA (PRWEB) May 01, 2015 The ... genetic makeup and the interplay of genes with one ... with developments can be daunting. , LabRoots, the premier ... clinical diagnostics professionals, will soon host its annual conference ... At BioConference Live Genetics and Genomics 2015 , ...
Breaking Medicine News(10 mins):Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3
... death improves cancer therapy efficacy , Individuals ... aggressive types of brain tumor, have an extremely ... a group of proteins known as receptor tyrosine ... with GBM, these RTK inhibitors have met with ...
... is a time of great excitement and anticipation. It ... women with type 1 or type 2 diabetes. Pregnancy ... But a new, easy-to-read booklet has information to help ... For Women with Diabetes: Your Guide to Pregnancy is ...
... neurodegenerative diseases, study says , , FRIDAY, Aug. ... human brain has the ability to grow new neurons, ... , The study included nine people with multiple sclerosis ... In MS, the immune system destroys the myelin sheaths ...
... LLC announced today it,has completed its previously announced ... Corporation (OTC Bulletin Board: IMMC) and its,wholly-owned subsidiaries., ... inventory,and clinical data as well as all technologies ... to automate the detection and enumeration,of circulating tumor ...
... BEACH, Calif., Aug. 1 Nationwide,Health Properties, Inc. (NYSE: ... declared a $0.44 per share dividend on the company,s ... to shareholders of record on August,15, 2008., In ... share,dividend on the Series B cumulative convertible preferred stock ...
... 43 National Chains; 6 Receive an ,F, NEW ... likely to,make your children fat? A year-long study of ... fast-food and sit-down,chain restaurants, according to the authors of ... David Zinczenko and Matt Goulding calculated,calories, fat (trans- and ...
Cached Medicine News:Health News:JCI online early table of contents: Aug. 1, 2008 2Health News:JCI online early table of contents: Aug. 1, 2008 3Health News:JCI online early table of contents: Aug. 1, 2008 4Health News:JCI online early table of contents: Aug. 1, 2008 5Health News:JCI online early table of contents: Aug. 1, 2008 6Health News:JCI online early table of contents: Aug. 1, 2008 7Health News:Neurons Can Re-Grow in Some MS Lesions 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 2Health News:NHP Declares Quarterly Cash Dividends on Common Stock and Series B Preferred Stock 3Health News:America's Worst Restaurants for Kids Revealed 2Health News:America's Worst Restaurants for Kids Revealed 3Health News:America's Worst Restaurants for Kids Revealed 4Health News:America's Worst Restaurants for Kids Revealed 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: